Clinical Trials Often the Best Option for Malignant Mesothelioma
Newly-diagnosed patients with malignant mesothelioma are forced to face a harsh reality early on in their cancer journey – there is no universally effective treatment for this aggressive cancer. In fact, as a highly resistant malignancy, mesothelioma is often unresponsive to even the “gold standard” treatment combination of pemetrexed (Alimta) and cisplatin. But that does not mean that mesothelioma patients do not have options. Clinical trials, the tools scientists use to test promising new mesothelioma treatments, are a good alternative for many patients. Clinical Trials of New Mesothelioma Treatments Although there can be a stigma around drug testing on human subjects, the FDA’s rules governing clinical trials today are strict. No drug can be used on a human subject until…